Verification vs Validation: Don't Let Your Medical Device Fail the Test

Why Getting Medical Device Verification vs Validation Wrong Costs You More Than You Think

Medical device verification vs validation are two distinct design control activities — and confusing them is one of the most common reasons devices fail FDA review, trigger 483 observations, or end up in a recall.

Here's the quick answer:

Verification Validation Core question Did we build the product right? Did we build the right product? What it checks Design outputs against design inputs Finished device against user needs and intended use When it happens Throughout development End of development, on production-equivalent units Regulatory basis 21 CFR 820.3(aa) / ISO 13485 Clause 7.3.6 21 CFR 820.3(z) / ISO 13485 Clause 7.3.7 Primary methods Testing, inspection, analysis, demonstration Simulated-use testing, clinical evaluation, usability testing Key output Objective evidence requirements are met High assurance device meets intended use

Both are mandatory under FDA design controls — but they serve fundamentally different purposes at different stages of your development lifecycle.

Why does this distinction matter so much in practice? Consider the stakes: approximately 60% of medical device recalls in recent years have been traced back to design-related issues, many stemming directly from insufficient or mislabeled V&V activities. Companies that get V&V right, on the other hand, report up to a 25% reduction in time-to-market and significantly lower post-market modification costs.

The confusion isn't just academic. A device can pass every verification test with flying colors — meeting every specification on paper — and still fail validation because the original design inputs didn't accurately capture what real users actually need in real conditions. That gap between specification compliance and real-world fitness is exactly where devices get into trouble.

I'm Stephen Ferrell, Chief Product Officer at Valkit.ai, and over more than two decades working across pharmaceutical, biotech, and medical device organizations on computerized system validation and GxP quality systems, I've seen how poorly scoped medical device verification vs validation activities quietly compound into costly regulatory setbacks. In this guide, I'll walk you through the regulatory definitions, practical methods, documentation requirements, and common pitfalls — so your team can execute V&V with confidence.

The Regulatory Definitions of Medical Device Verification vs Validation

To navigate V&V successfully, we must look at how regulatory bodies define these terms.

Under the FDA's 21 CFR 820.30 (and the newly integrated Quality System Management Regulation, or QMSR), Design Verification is defined as:

"Confirmation by examination and provision of objective evidence that specified requirements have been fulfilled."

Meanwhile, Design Validation is defined as:

"Confirmation by examination and provision of objective evidence that the particular requirements for a specific intended use can be consistently fulfilled."

ISO 13485:2016 mirrors these concepts in Clauses 7.3.6 and 7.3.7. Under ISO 13485, verification ensures that design outputs meet design inputs, while validation ensures that the resulting medical device is capable of meeting the requirements for the specified application or intended use.

All of this critical evidence must be compiled systematically within your Design History File (DHF). The DHF serves as the ultimate proof for auditors that you followed a structured design control process. Interestingly, medical device manufacturers with ISO 13485 certification report 30% fewer design control nonconformities during audits compared to non-certified firms, highlighting how a structured quality management system (QMS) directly translates to better compliance.

For a deeper dive into how these distinctions shape your technical documentation, the Team-NB explanation of V&V differences provides an excellent European notified body perspective on maintaining a robust conformity assessment.

How Design Inputs and Outputs Drive Medical Device Verification vs Validation

The entire V&V process is powered by the relationship between design inputs and design outputs.

• Design Inputs are the physical and performance requirements of a device based on its intended use and user needs. Think of these as your instructions: "The device must operate on battery power for at least 8 hours," or "The enclosure must withstand a 1-meter drop."
• Design Outputs are the actual drawings, specifications, software code, and manufacturing instructions that define the physical device. This is what you actually built.

Design verification is the bridge between these two. It answers: "Did we build the product right?" It is a strictly objective, engineering-focused exercise. If the design input required an 8-hour battery life, verification involves bench-testing the battery under load to prove it lasts at least 8 hours. By providing clear, documented objective evidence, you prove that your outputs match your inputs.

Design validation, on the other hand, steps back to ask: "Did we build the right product?" It evaluates whether the outputs actually solve the user's problem. To learn how to structure this strategy without wasting months of engineering time, check out our insights on More info about design validation services.

Key Differences in Software Lifecycle: Medical Device Verification vs Validation

When dealing with software—whether it is Software in a Medical Device (SiMD) or Software as a Medical Device (SaMD)—the V&V boundaries are governed strictly by IEC 62304.

IEC 62304 establishes a life cycle framework that depends heavily on software safety classifications:

• Class A: No injury or damage to health is possible.
• Class B: Non-serious injury is possible.
• Class C: Death or serious injury is possible.

Under IEC 62304, software verification is highly structured and occurs at multiple levels:

1. Software Unit Verification: Testing individual software units (often through automated unit tests) to ensure they perform as designed.
2. Software Integration Testing: Verifying that different software units work together seamlessly without data corruption.
3. Software System Testing: Testing the complete, integrated software package against overall software requirements.

Crucially, IEC 62304 does not cover software validation. It explicitly states that validation is a device-level activity. You cannot validate software in isolation on a developer's laptop; software validation must be performed on the final, physical device (or in its complete, simulated production environment for SaMD) to ensure it satisfies user needs. For a comprehensive roadmap on this division, read this Guide to software verification and validation.

Mapping V&V to the V-Model and the Requirements Traceability Matrix (RTM)

The classic V-model is the gold standard for visualizing how design controls connect. The left side of the "V" represents the decomposition of requirements (from high-level user needs down to component-level specifications). The right side represents the execution of V&V activities.

To make this model work, you need bidirectional traceability. This means you must be able to trace a user need down to a design input, down to a design output, and then across to a specific verification test case and validation protocol.

This traceability is managed through a Requirements Traceability Matrix (RTM). A robust RTM ensures that:

• Every single design input is verified by at least one verification test.
• Every user need is validated by at least one validation activity.
• Every risk control measure identified in your ISO 14971 risk management file is verified and validated.
• Every General Safety and Performance Requirement (GSPR) checklist item is backed by objective testing evidence.

Without an RTM, it is nearly impossible to prove to auditors that your device is fully compliant. If a single link in this chain is broken, your entire regulatory submission could be put on hold.

The Four Primary Verification Methods

Design verification is not limited to physical bench testing. Regulatory bodies recognize four primary verification methods, and choosing the right one depends on your specific design input:

1. Testing: The most common method. It involves physical, quantitative evaluation of a device under controlled conditions (e.g., measuring tensile strength, battery life, or electromagnetic compatibility).
2. Inspection: Visual or dimensional examination of a design output against requirements (e.g., inspecting a label to verify that the required warning symbols are present, or checking CAD models to ensure physical dimensions match tolerances).
3. Analysis: Using mathematical modeling, simulations, or engineering calculations to prove a requirement is met (e.g., performing a finite element analysis to verify structural integrity under load when physical testing is destructive or impractical).
4. Demonioration: A qualitative showing that a feature works as intended without generating precise numerical data (e.g., demonstrating that an alarm screen successfully flashes red when a simulated fault occurs).

All verification activities must be governed by pre-approved verification protocols that define the test setup, equipment calibration, sample sizes, and clear, objective pass/fail acceptance criteria before testing begins.

Why Validation Requires Production-Equivalent Units

One of the most common FDA 483 findings is performing design validation on prototypes. Design validation must be performed on initial production units, lots, or batches (or their close equivalents).

Why? Because prototypes built by hand in an R&D lab do not reflect the variability of a commercial manufacturing line. If your production process introduces minor dimensional shifts, material changes, or sterilization stresses, the device may behave differently in the field than your pristine lab prototype did.

Validation activities focus heavily on:

• Simulated-use testing: Having real users (like doctors or patients) interact with the device in a simulated environment (such as a mock operating room or home setting).
• Actual use conditions: Testing environmental extremes, transport stress, and user fatigue.
• ASTM F1980 accelerated aging: Verifying that the device and its packaging maintain sterile integrity and performance over its claimed shelf-life.
• ISO 10993-1 biocompatibility: Proving that the materials in contact with the patient do not cause toxic, inflammatory, or biological reactions over time.

For an in-depth look at how to structure these end-of-lifecycle sterile barrier checks, read our comprehensive More info about sterilization validation.

Specialized V&V Workflows: Software, Usability, and Electrical Safety

As medical devices grow more complex, V&V must expand beyond basic mechanical testing to cover specialized, multi-disciplinary workflows:

• IEC 60601-1 (Electrical Safety & EMC): Active medical devices must undergo rigorous testing to ensure they do not shock patients, overheat, or interfere electromagnetically with other hospital equipment. This is a critical component of design verification.
• IEC 62366-1 (Usability Validation): Human factors engineering is no longer optional. Usability validation involves conducting a summative evaluation with representative users. You must prove that the user interface minimizes use errors and that the device can be operated safely under realistic conditions.
• Clinical Evaluation: For many devices, validation culminates in a clinical evaluation report (CER) or active clinical trials, proving that the device achieves its intended clinical benefit in real patients.

Managing these distinct streams of data requires a highly coordinated quality system. For a breakdown of how to orchestrate these workflows seamlessly, explore our guide on More info about validation services.

Regulatory Pitfalls: FDA 483 Observations and the QMSR Transition

The regulatory landscape is becoming increasingly strict. FDA warning letters for medical device manufacturers increased by 70% from 2022 to 2023, with design control deficiencies (including inadequate verification and validation) cited in over 40% of cases.

Furthermore, over 80% of FDA 483 observations related to design controls in recent years involved failures to adequately document verification or validation activities in the DHF. Common mistakes include:

• Failing to establish acceptance criteria before running a test.
• Using inadequate statistical justifications for sample sizes.
• Failing to re-verify or re-validate after making a minor design change.

This documentation burden is feeling even heavier now that the FDA's Quality System Management Regulation (QMSR) is fully in effect. The QMSR officially harmonizes FDA 21 CFR 820 with ISO 13485:2016, specifically aligning US expectations with ISO Clause 7.3. This means inspectors are looking for strict, ISO-style system-level validation and bidirectional traceability.

Navigating this transition without the right digital tools is a recipe for compliance bottlenecks. To see how modern software can protect your pipeline, check out our More info about compliance software.

Frequently Asked Questions about Medical Device V&V

Can a medical device pass verification but fail validation?

Absolutely. A classic example is an automated external defibrillator (AED) designed for emergency street use. During verification, engineers confirm that the device successfully delivers a 150-joule shock (meeting the design input specification).

However, during validation in a simulated emergency scenario, researchers discover that the screen's text is too small to read in direct sunlight, and stress-induced bystanders cannot figure out where to plug in the pads. The device met its technical specifications (verification passed) but failed to meet the user's real-world needs (validation failed).

Is design validation required for Class I medical devices?

Under FDA 21 CFR 820.30, certain Class I devices are exempt from design controls. However, if your Class I device features software, is automated, or is a surgical glove, protective restraint, or radionuclide applicator, design controls (including validation) are fully applicable.

Furthermore, even if a Class I device is legally exempt from design controls under FDA rules, ISO 13485:2016 does not recognize these exemptions. If you want to market your Class I device globally, you must perform and document both verification and validation.

How does the 2026 QMSR transition affect V&V documentation?

The QMSR transition means the FDA has replaced its legacy Quality System Regulation with a framework that directly references ISO 13485:2016. For V&V, this means your documentation must explicitly reflect the language of ISO Clauses 7.3.5 (Verification) and 7.3.6 (Validation).

Traceability must extend beyond the device itself to include interfaces with other systems, and software validation must be documented using a risk-based approach. To understand how artificial intelligence and advanced software fit into this new regulatory era, read More info about AI compliance.

Conclusion

Executing medical device verification vs validation with precision is the difference between a smooth, profitable product launch and a multi-million-dollar regulatory nightmare. But building manual traceability matrices, writing hundreds of testing protocols, and managing physical paper trails in spreadsheets is a massive drain on your engineering resources.

At Valkit.ai, we built an AI-powered digital validation platform designed specifically to solve this headache. Operating out of our hubs in Scotland and Indiana, we help pharmaceutical, biotech, and medical device companies automate the most painful parts of the compliance lifecycle.

By leveraging smart automations, template cloning, and real-time compliance tracing, Valkit.ai reduces validation costs by up to 80% and compresses validation timelines from weeks to mere hours.

Don't let manual paperwork slow down your life-saving innovations. Discover how we can streamline your design controls by visiting the Valkit.ai Validation Platform, or read More info about validation software to see our platform in action.